A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency
Authors:
- 1 November 2000
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 294 (3) , 147-150
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3Journal of Neurochemistry, 2000
- Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced ApoptosisJournal of Biological Chemistry, 2000
- Ribozyme-Mediated Inhibition of Caspase-3 Protects Cerebellar Granule Cells from Apoptosis Induced by Serum–Potassium DeprivationThe Journal of Neuroscience, 2000
- Caspase Independent/Dependent Regulation of K+, Cell Shrinkage, and Mitochondrial Membrane Potential during Lymphocyte ApoptosisJournal of Biological Chemistry, 1999
- Partial lithium-associated protection against apoptosis induced by C2-ceramide in cerebellar granule neuronsNeuroReport, 1998
- Programmed cell death: Does it play a role in parkinson's disease?Annals of Neurology, 1998
- The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphatesProceedings of the National Academy of Sciences, 1997
- Magnesium reversal of lithium inhibition of β-adrenergic and muscarinic receptor coupling to G proteinsBiochemical Pharmacology, 1991
- The effect of K+ and glutamate receptor agonists on the membrane potential of suspensions of primary cultures of rat astrocytes as measured with a cyanine dye, DiS-C2-(5)Brain Research, 1988
- Lithium and inositol lipid-linked signalling mechanismsTrends in Pharmacological Sciences, 1987